Missing a single dose may cause temporary increases in blood glucose levels for diabetes patients and reduced appetite control for weight management patients
The company has already terminated subscriptions of existing members for compounded GLP-1 medications who do not plan to use the brand-name medications
They have also been shown to increase body weight and to improve insulin sensitivity and -cell function, similar to our observation with nonweight-loss prediabetes remission 45,47
Your provider will determine the appropriate switching dose based on your individual response, side effect profile, and treatment goals
BMC Endocr Disord 23(1):46 Yin M, Wang Y, Han M et al (2023) Mechanisms of bariatric surgery for weight loss and diabetes remission
noted that although gastrointestinal issues have been related to GLP-1 antagonist use, they consider a diagnosis of gastroparesis to be unusual. Hyposalivation Research has found that semaglutide can cause secondary xerostomia, otherwise known as dry mouth (19)